# Intravitreal Bevacizumab versus Combined Bevacizumab-Triamcinolone versus Macular Laser Photocoagulation in Diabetic Macular Edema

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/intravitreal-bevacizumab-versus-combined-bevacizumab-triamcinolone-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hooshang Faghihi,Ramak Roohipoor,Seyed-Farzad Mohammadi,K. Hojat-Jalali,Ahmad Mirshahi,A. Lashay,Niloofar Piri,S. Vahid Faghihi |
| Citations | 99 |
| DOI | 10.1177/112067210801800614 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2160821049 |
| PMID | 18988166 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Seyed-Farzad Mohammadi](https://scholariq.org/researchers/seyed-farzad-mohammadi/)

## Paper journal

- [European Journal of Ophthalmology](https://scholariq.org/journals/european-journal-of-ophthalmology/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.